• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Dynatronics Corporation filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

    6/28/24 8:01:12 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care
    Get the next $DYNT alert in real time by email
    Dynatronics Corp.: Form 8-K - Filed by newsfilecorp.com

    false 2024-06-27 0000720875 Dynatronics Corp. 0000720875 2024-06-27 2024-06-27

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________________

    FORM 8-K

    CURRENT REPORT
    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): June 27, 2024

    DYNATRONICS CORP.
    (Exact name of registrant as specified in its charter)

    Utah 000-12697 87-0398434
    (State or other jurisdiction (Commission (IRS Employer
    of incorporation) File Number) Identification No.)

    1200 Trapp Rd.
    Eagan, Minnesota, United States 55121
    (Address of principal executive offices) (ZIP Code)

    Registrant's telephone number, including area code: (801) 568-7000

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: (see General Instruction A.2. below):

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each class   Trading Symbols   Name of each exchange on which registered
    Common stock, no par value   DYNT   NASDAQ Capital Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


    Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

    As previously disclosed, on December 27, 2023, Dynatronics Corporation (the "Company") received written notice from The Nasdaq Stock Market ("Nasdaq") that if the Company's common stock failed to regain compliance with Nasdaq's minimum bid price requirement before June 24, 2024, the Company's common stock would be delisted from Nasdaq. On June 27, 2024, Dynatronics received written notice from Nasdaq that trading of the Company's common stock will be suspended at the open of business on July 9, 2024 due to Dynatronics' failure to regain compliance with the minimum bid price requirement. Following such suspension, Nasdaq is expected to file a Form 25 Notification of Delisting with the Securities Exchange Commission with respect to Dynatronics' common stock when all internal procedural periods have run.

    Prior to receiving Nasdaq's written notice, the Company considered its alternatives and concluded that transitioning to The OTC Markets Group, Inc. ("OTC") is the best course of action given recurring instances of noncompliance with Nasdaq listing requirements, and has determined not to appeal Nasdaq's determination. The OTC has approved the quotation of the Company's common stock on the OTCQB Venture Market ("OTCQB") and the Company's common stock is expected to be quoted on OTCQB immediately following its suspension of trading on Nasdaq on July 9, 2024. The ticker symbol and CUSIP for the Company's common stock is not expected to change in connection with its suspension and delisting from Nasdaq and commencement of quotation on the OTCQB. Shareholders of the Company's common stock are not required to take any action.

    The Company will continue to remain a reporting company under the Securities Exchange Act of 1934, as amended, and the transition to OTCQB is not expected to affect the Company's business operations.

    Item 7.01. Regulation FD Disclosure.

    On June 28, 2024, the Company issued a press release relating to its intention to have its common stock traded on OTCQB following their delisting from Nasdaq.

    This Item 7.01 of this Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 are being furnished to the Securities and Exchange Commission under Item 7.01 of Form 8-K in satisfaction of the public disclosure requirements of Regulation FD and shall not be deemed "filed" for any purpose.

    Cautionary Note Regarding Forward-Looking Statements

    Certain statements included in this Current Report on Form 8-K constitute "forward-looking statements" within the meaning of federal securities laws. These forward-looking statements are based on current expectations and assumptions that involve risks and uncertainties and on information available to the Company as of the date hereof. Statements regarding the delisting of the Company's common stock from Nasdaq and the future trading of the Company's common stock on OTCQB are "forward-looking statements" and are subject to known and unknown risks and uncertainties that may cause actual results to differ materially from those expressed in such forward-looking statements. Additional information concerning these and other important risks and uncertainties can be found in the Company's filings with the SEC, including the Company's Annual Report on Form 10-K for the year ended June 30, 2023, as filed on September 28, 2023. The Company undertakes no obligation to update any forward-looking statements to reflect subsequent events or circumstances.

    Item 9.01. Financial Statements and Exhibits.

    (d) Exhibits

    Exhibit
    No.
       Description
    99.1   Press Release, dated June 28, 2024.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

    Date: June 27, 2024

      DYNATRONICS CORPORATION
         
      By: /s/ Brian Baker
        Name: Brian Baker
        Title:  Chief Executive Officer



    Get the next $DYNT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DYNT

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DYNT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Essig Stuart acquired 16,095 shares, increasing direct ownership by 0.30% to 4,533,824 units (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/30/25 9:10:45 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Large owner Provco Ventures 1 Lp acquired 8,043 shares, increasing direct ownership by 0.29% to 2,739,998 units (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/30/25 9:10:25 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Director Enright Erin S. acquired 16,095 shares (SEC Form 4)

    4 - DYNATRONICS CORP (0000720875) (Issuer)

    10/30/25 8:04:18 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    SEC Filings

    View All

    Dynatronics Corporation filed SEC Form 8-K: Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Leadership Update

    8-K - DYNATRONICS CORP (0000720875) (Filer)

    1/12/26 4:15:58 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - DYNATRONICS CORP (0000720875) (Filer)

    12/17/25 8:10:02 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Dynatronics Corporation

    10-Q - DYNATRONICS CORP (0000720875) (Filer)

    11/19/25 9:36:08 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

    Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

    1/8/24 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Appointment of Dr. Christopher von Jako as new CEO

    Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

    6/21/23 9:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

    Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

    5/18/23 8:05:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Leadership Updates

    Live Leadership Updates

    View All

    Leixir Dental Laboratory Group Appoints John Krier as Chief Executive Officer

    Leixir Dental Laboratory Group (Leixir), a leading operator of a full-service, state-of-the-art dental laboratory network, today announced the appointment of John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier succeeds Leixir founder Harmeet Bindra, who will continue as Executive Chairman. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries. He joins Leixir from Dynatronics Corporation (NASDAQ:DYNT), where he was most recently President and CEO. Before that, he held senior roles in corporate strategy and commercial execution, including marketing and customer experience, over seven

    1/8/24 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Appointment of Dr. Christopher von Jako as new CEO

    Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company's Board of Directors has appointed Christopher von Jako, Ph.D. ("Dr. von Jako") as Chief Executive Officer and director of the Company, effective immediately. Dr. von Jako succeeds Richard Hullihen, who will be retiring and will be stepping down as a Director of the Company, effective immediately. Mr. Hullihen will assist the Company in a transitional position for the next six months. Since his appointment as CEO in 2017, Richard has overseen significant progress for Polarean. He led the Company through its successful IPO in 2018 and over $60M of ca

    6/21/23 9:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Announces Planned Resignation of John Krier as CEO; Brian Baker Appointed President and CEO Successor After Transition

    Consistency of Executive Leadership Expected to Provide Smooth TransitionEagan, Minnesota--(Newsfile Corp. - May 18, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that Chief Executive Officer and Director John Krier has informed the Board of his intention to resign from the company by the end of September 2023 to pursue other professional interests. Brian Baker, the company's current Chief Operating Officer, and former President and Chief Executive Officer, has accepted the role of President of Dynatronics effective immediately and will assume the titles of President, Chief Executive

    5/18/23 8:05:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Financials

    Live finance-specific insights

    View All

    Dynatronics Corporation Reports Third Quarter Fiscal Year 2023 Financial Results and Business Highlights

    Eagan, Minnesota--(Newsfile Corp. - May 11, 2023) - Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its third quarter of fiscal year 2023 ended March 31, 2023, and provided an update on the business.CEO Commentary"Dynatronics experienced revenue challenges in our third fiscal quarter as a result of three external factors. As a result, we are adjusting our spending and revenue expectations as we respond to the specific impacts of:Competitive acquisitions by a significant rehabilitation customer; Reduction in specific SKUs of an OEM customer for the

    5/11/23 7:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation Schedules Conference Call to Report Third Quarter Results for Fiscal 2023

    Eagan, Minnesota--(Newsfile Corp. - April 27, 2023) - Dynatronics Corporation (NASDAQ:DYNT), a leading manufacturer of athletic training, physical therapy, and rehabilitation products, today announced that the company will release financial results for its third quarter of fiscal year 2023 on Thursday, May 11, 2023 before the market opens.The company will subsequently hold a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session with analysts, at 8:00 AM ET on Thursday, May 11, 2023, to review its third quarter results.Interested persons may access the live conference call by dialing 1-800-319-4610 (U.S./Canada calle

    4/27/23 8:00:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    Dynatronics Corporation Reports Second Quarter Fiscal Year 2023 Financial Results and Business Highlights

    EAGAN, MN / ACCESSWIRE / February 9, 2023 / Dynatronics Corporation (NASDAQ:DYNT) ("Dynatronics" or the "Company"), a manufacturer of athletic training, physical therapy, and rehabilitation products, today reported financial results for its second quarter of fiscal year 2023 ended December 31, 2022, and provided an update on the business.CEO Commentary"The year-over-year improvement in gross margin of 8.4% or nearly $1.0 million in gross profit was a solid improvement. We are pleased with our progression, but we have more work to do. New, targeted, and innovative, product releases are the third pillar of our gross margin improvement plan, and we plan to continue to improve our performance in

    2/9/23 7:30:00 AM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    $DYNT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    2/14/23 12:35:29 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    2/13/23 12:33:51 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Dynatronics Corporation (Amendment)

    SC 13G/A - DYNATRONICS CORP (0000720875) (Subject)

    1/14/22 12:22:28 PM ET
    $DYNT
    Medical/Dental Instruments
    Health Care